StockNews.AI • 9 days
New digital health platform being launched in partnership with UCSD allows remote physician-monitore...
Original sourceNexalin Technology has launched its AI-designed virtual clinic platform, NeuroCare™, in partnership with UC San Diego. This groundbreaking initiative aims to enhance patient access, reduce costs, and provide continuous care in brain health, potentially driving significant long-term revenue and improved patient outcomes across various critical conditions.
The launch of NeuroCare could significantly increase patient engagement and revenue. Historically, companies with innovative digital health solutions have experienced substantial stock price appreciation post-launch.
Buy NXL for long-term growth as new platform may transform revenue model by 2026.
This falls under 'Corporate Developments' as it represents a significant strategic initiative in Nexalin's operations, integrating advanced technology to broaden their service offering and revenue potential.